In vitro expanded cells contributing to rapid severe combined immunodeficient repopulation activity are CD34+38-33 +90+45RA-

Stem Cells

Volumn 25, Issue 1, 2007, Pages 107-114

  Vanheusden, Katrien ^a   Van Coppernolle, Stefanie ^b   De Smedt, Magda ^a   Plum, Jean ^a   Vandekerckhove, Bart ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b BTCO Dienst Voor Het Bloed   (Belgium)

Author keywords

Hematopoiesis; Nonobese diabetic severe combined immunodeficient mice; Stem cell; Stem cell culture

Indexed keywords

CELL MARKER;

ANIMAL CELL; ARTICLE; CD34 SELECTION; CELL FRACTIONATION; CELL POPULATION; CELL TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FLOW CYTOMETRY; IN VITRO STUDY; MOUSE; NONHUMAN; PHENOTYPE; POPULATION DYNAMICS; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CORD BLOOD STEM CELL TRANSPLANTATION; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; PLURIPOTENT STEM CELLS; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 33845984504     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0256     Document Type: Article

References (42)

1. Kurtzberg J, Laughlin M, Graham ML et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-166.
2. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-1577.
3. Wagner JE, Barker JN, DeFor TE et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-1618.
4. Mazurier F, Doedens M, Gan OI et al. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 2003;9:959-963.
5. Kerre TCC, De Smet G, De Smedt M et al. Both CD34+38+ and CD34+38- cells home specifically to the bone marrow of NOD/LtSZ scid/scid mice but show different kinetics in expansion. J Immunol 2001;167:3692-3698.
6. McKenzie JL, Gan OI, Doedens M et al. Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells. Blood 2005;106:1259-1261.
7. Shultz LD, Banuelos SJ, Leif J et al. Regulation of human short-term repopulating cell (STRC) engraftment in NOD/SCID mice by host CD122+ cells. Exp Hematol 2003;31:551-558.
8. Hogan CJ, Shpall EJ, Keller G. Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci U S A 2002;99:413-418.
9. Glimm H, Eisterer W, Lee K et al. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J Clin Invest 2001;107:199-206.
10. Mazurier F, Gan OI, McKenzie JL et al. Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 2004;103:545-552.
11. Dorrell C, Gan OI, Pereira DS et al. Expansion of human cord blood CD34+CD38- cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function. Blood 2000;95:102-110.
12. Bhatia M, Bonnet D, Kapp U et al. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 1997;186:619-624.
13. Piacibello W, Sanavio F, Severino A et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34+ cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999;93:3736-3749.
14. Kobari L, Pflumio F, Giarratana M-C et al. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34+ cord blood cells. Exp Hematol 2000;28:1470-1480.
15. Araki H, Mahmud N, Milhem M et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. Exp Hematol 2006;34:140-149.
16. Conneally E, Cashman J, Petzer A et al. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci U S A 1997;94:9836-9841.
17. Shpall EJ, Quinones R, Giller R et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002;8:368-376.
18. Kusadasi N, van Soest PL, Mayen AE et al. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood. Leukemia 2000;14:1944-1953.
19. Jaroscak J, Goltry K, Smith A et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: Results of a phase 1 trial using the AastromReplicell System. Blood 2003;101:5061-5067.
20. McNiece I, Jones R, Bearman SI et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000;96:3001-3007.
21. Mayani H, Lansdorp P. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994;83:2410-2417.
22. Danet GH, Lee HW, Luongo JL et al. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34+ cells after ex vivo expansion. Exp Hematol 2001;29:1465-1473.
23. Xu R, Reems J. Umbilical cord blood progeny cells that retain a CD34+ phenotype after ex vivo expansion have less engraftment potential than unexpanded CD34+ cells. Transfusion 2001;41:213-218.
24. Punzel M, Gupta P, Verfaillie CM. The microenvironment of AFT024 cells maintains primitive human hematopoiesis by counteracting contact mediated inhibition of proliferation. Cell Commun Adhes 2002;9:149-159.
25. Punzel M, Moore K, Lemischka I et al. The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells. Leukemia 1999;13:92-97.
26. Bennaceur-Griscelli A, Pondarre C, Schiavon V et al. Stromal cells retard the differentiation of CD34+CD38low/neg human primitive progenitors exposed to cytokines independent of their mitotic history. Blood 2001;97:435-441.
27. Breems DA, Blokland EA, Siebel KE et al. Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells. Blood 1998;91:111-117.
28. Issaad C, Croisille L, Katz A et al. A murine stromal cell line allows the proliferation of very primitive human CD34++/CD38- progenitor cells in long-term cultures and semisolid assays. Blood 1993;81:2916-2924.
29. Cashman JD, Eaves CJ. Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient mice. Blood 1999;93:481-487.
30. Keeney M, Chin-Yee I, Weir K. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. Cytometry 1998;34:61-70.
31. Bennaceur-Griscelli A, Tourino C, Izac B et al. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34+CD38low/neg human bone marrow cells. Blood 1999;94:529-538.
32. Itoh K, Tezuka H, Sakoda H et al. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol 1989;17:145-153.
33. Bryder D, Jacobsen SEW. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood 2000;96:1748-1755.
34. Varnum-Finney B, Brashem-Stein C, Bernstein ID. Combined effects of Notch signaling and cytokines induce a multiple log increase in precursors with lymphoid and myeloid reconstituting ability. Blood 2003;101:1784-1789.
35. Glimm H, Schmidt M, Fischer M et al. Evidence of similar effects of short-term culture on the initial repopulating activity of mobilized peripheral blood transplants assessed in NOD/SCID-[beta] 2microglobulinnull mice and in autografted patients. Exp Hematol 2005;33:20-25.
36. Verhasselt B, Kerre T, Naessens E et al. Thymic repopulation by CD34+ human cord blood cells after expansion in stroma-free culture. Blood 1999;94:3644-3652.
37. Blom B, Spits H. Development of human lymphoid cells. Annu Rev Immunol 2006;24:287-320.
38. Haddad R, Guardiola P, Izac B et al. Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood. Blood 2004;104:3918-3926.
39. Benveniste P, Cantin C, Hyam D et al. Hematopoietic stem cells engraft in mice with absolute efficiency. Nat Immunol 2003;4:708-713.
40. Guenechea G, Gan OI, Dorrell C et al. Distinct classes of human stem cells that differ in proliferative and self-renewal potential. Nat Immunol 2001;2:75-82.
41. Sieburg HB, Cho RH, Dykstra B et al. The hematopoietic stem compartment consists of a limited number of discrete stem cell subsets. Blood 2006;107:2311-2316.
42. Kerre TCC, De Smet G, De Smedt M et al. Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34+ cells. Blood 2002; 99:1620-1626.